Back

LDL on target - strike early and strike strong... just strike...

1 September 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Drug therapy (2) Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Lucas Hamann

Algarve University Hospital Center, Faro (Portugal)

6 More presentations in this session

Presentation thumbnail
Bempedoic acid in clinical practice.
Doctor J. Vazquez Reguera (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study
Assistant Professor Z. Yang (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of Alirocumab once-monthly dosing in patients with atherosclerotic cardiovascular disease and without acute coronary syndrome or stroke; an ODYSSEY CHOICE I analysis
Doctor C. Bonanad Lozano (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
VICTORION IMPLEMENT: an observational study of the lipid management landscape in Germany
Professor O. Weingaertner (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Analytical approaches to open label extension (OLE) after cardiovascular outocmes trials: Observations from the FOURIER and FOURIER-OLE trials
Doctor H. Wang (Newbury Park, US)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy (2)

The Event

Event poster

ESC Congress 2025

1 September 2025 12:15 CET
You may be interested in
thumbnail
Congress Session
LDL-C reduction in acute coronary syndrome: strike early and strike strong
thumbnail
Congress Presentation
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
thumbnail
Congress Presentation
Strike Early and Strike Strong: application of a strategy comprising first-line combination of high-intensity statins and ezetimibe for patients with acute myocardial infarction in routine practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources